Compare MTEN & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTEN | HKPD |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | China | Hong Kong |
| Employees | N/A | N/A |
| Industry | Building Products | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4M | 9.2M |
| IPO Year | 2022 | 2024 |
| Metric | MTEN | HKPD |
|---|---|---|
| Price | $1.05 | $0.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.6M | ★ 3.6M |
| Earning Date | 05-21-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.02 | $0.12 |
| 52 Week High | $12.75 | $1.82 |
| Indicator | MTEN | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 46.87 | 21.40 |
| Support Level | $0.97 | N/A |
| Resistance Level | $1.07 | $0.71 |
| Average True Range (ATR) | 0.07 | 0.05 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 34.36 | 1.46 |
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup, including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.